0001562180-24-005719.txt : 20240715
0001562180-24-005719.hdr.sgml : 20240715
20240715161156
ACCESSION NUMBER: 0001562180-24-005719
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240606
FILED AS OF DATE: 20240715
DATE AS OF CHANGE: 20240715
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: REICIN ALISE
CENTRAL INDEX KEY: 0001757533
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39941
FILM NUMBER: 241117415
MAIL ADDRESS:
STREET 1: C/O CELGENE CORPORATION
STREET 2: 86 MORRIS AVENUE
CITY: SUMMIT
STATE: NJ
ZIP: 07901
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Sana Biotechnology, Inc.
CENTRAL INDEX KEY: 0001770121
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 188 EAST BLAINE STREET, SUITE 400
CITY: SEATTLE
STATE: WA
ZIP: 98102
BUSINESS PHONE: (206) 701-7914
MAIL ADDRESS:
STREET 1: 188 EAST BLAINE STREET, SUITE 400
CITY: SEATTLE
STATE: WA
ZIP: 98102
4/A
1
primarydocument.xml
PRIMARY DOCUMENT
X0508
4/A
2024-06-06
2024-06-07
false
0001770121
Sana Biotechnology, Inc.
SANA
0001757533
REICIN ALISE
C/O SANA BIOTECHNOLOGY, INC.
188 EAST BLAINE STREET, SUITE 400
SEATTLE
WA
98102
true
false
false
false
false
Stock Option (Right to Buy)
7.36
2024-06-06
4
A
false
65000.00
0.00
A
2034-06-05
Common Stock
65000.00
65000.00
D
This Form 4/A is being filed to correct a clerical error with regard to the number of option shares acquired.
The option vests and becomes exercisable as to 100% of the underlying shares on the earlier of (i) June 6, 2025 and (ii) immediately prior to the 2025 annual meeting of stockholders of Sana Biotechnology, Inc. ("Sana"), provided that the reporting person provides continuous service to Sana through such date.
/s/ Julie Shah, Attorney-in-Fact for Alise Reicin
2024-07-15